Clinuvel Pharmaceuticals (CLVLF) Stock Price, Quote, News & History

Comments

Clinuvel Pharmaceuticals Ltd (CLVLF) Stock Price, Quote, News & History

CLVLFOTCPK

Trade with Public

$8.45

0.0350.42%

At close: Jan 26, 4:00 PM EST

OverviewNews Short Interest

Key Statistics

Open

$8.45

Volume / Avg.

0 / 711.00

Day Range

- - -

52 Wk Range

6.81 - 8.60

Market Cap

$424.20M

P/E Ratio

18.56

Dividend Yield

0.39%

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

Recent Clinuvel Pharmaceuticals Ltd News

Stocks That Hit 52-Week Lows On Friday

Lisa Levin

Stocks That Hit 52-Week Lows On Thursday

Lisa Levin

Stocks That Hit 52-Week Lows On Tuesday

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

Investing Cash Flow (TTM)

-18.64M

Financing Cash Flow (TTM)

-2.71M

Free Cash Flow (TTM)

40.08M

Capital Expenditure (TTM)

-390.18K

Net Change in Cash (TTM)

19.12M

Valuation Metrics

Enterprise Value

$192.80M

PE Ratio (TTM)

18.56

PE Ratio (FWD)

14.88

PEG Ratio (TTM)

PS Ratio (TTM)

6.28

PB Ratio (TTM)

2.41

Earnings Yield % (TTM)

5.39%

Earnings Yield % (FWD)

6.72%

EV / EBITDA (TTM)

5.38

Price / EBITDA (TTM)

12.01

Price / Free Cash Flow (TTM)

15.08

Book Value / Share

$3.51

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$224.11M

Debt to Equity

0.00

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$8.45

Volume / Avg.

0 / 711.00

Day Range

- - -

52 Wk Range

6.81 - 8.60

Market Cap

$424.20M

P/E Ratio

18.56

Dividend Yield

0.39%

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

About

Sector

Health Care

Industry

Biotechnology

Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to li...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Clinuvel Pharmaceuticals (CLVLF) stock?

You can purchase shares of Clinuvel Pharmaceuticals (OTCPK:CLVLF) through any online brokerage.

View our list of the best stock brokerages

Who are Clinuvel Pharmaceuticals (CLVLF) competitors?

There are no as such competitors for Clinuvel Pharmaceuticals.

What is the forecast, or price target, for Clinuvel Pharmaceuticals (CLVLF) stock?

There is no analysis for Clinuvel Pharmaceuticals to provide a consensus price target.

What is the current price for Clinuvel Pharmaceuticals (CLVLF)?

The stock price for Clinuvel Pharmaceuticals (OTCPK: CLVLF) is $8.45 last updated January 27, 2026 at 10:17 AM EST.

Does Clinuvel Pharmaceuticals (CLVLF) pay a dividend?

There are no upcoming dividends for Clinuvel Pharmaceuticals.

When is Clinuvel Pharmaceuticals (OTCPK:CLVLF) reporting earnings?

Clinuvel Pharmaceuticals does not have any upcoming earnings scheduled.

Is Clinuvel Pharmaceuticals (CLVLF) going to split?

There is no upcoming split for Clinuvel Pharmaceuticals.

What sector and industry does Clinuvel Pharmaceuticals (CLVLF) operate in?

Clinuvel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.

Key Statistics

Open

$8.45

Volume / Avg.

0 / 711.00

Day Range

- - -

52 Wk Range

6.81 - 8.60

Market Cap

$424.20M

P/E Ratio

18.56

Dividend Yield

0.39%

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

Recent Clinuvel Pharmaceuticals Ltd News

Stocks That Hit 52-Week Lows On Friday

Lisa Levin

Stocks That Hit 52-Week Lows On Thursday

Lisa Levin

Stocks That Hit 52-Week Lows On Tuesday

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

Investing Cash Flow (TTM)

-18.64M

Financing Cash Flow (TTM)

-2.71M

Free Cash Flow (TTM)

40.08M

Capital Expenditure (TTM)

-390.18K

Net Change in Cash (TTM)

19.12M

Valuation Metrics

Enterprise Value

$192.80M

PE Ratio (TTM)

18.56

PE Ratio (FWD)

14.88

PEG Ratio (TTM)

PS Ratio (TTM)

6.28

PB Ratio (TTM)

2.41

Earnings Yield % (TTM)

5.39%

Earnings Yield % (FWD)

6.72%

EV / EBITDA (TTM)

5.38

Price / EBITDA (TTM)

12.01

Price / Free Cash Flow (TTM)

15.08

Book Value / Share

$3.51

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$224.11M

Debt to Equity

0.00

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$8.45

Volume / Avg.

0 / 711.00

Day Range

- - -

52 Wk Range

6.81 - 8.60

Market Cap

$424.20M

P/E Ratio

18.56

Dividend Yield

0.39%

Exchange

OTC

RSI

Short Interest

Days to Cover

999.99

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Clinuvel Pharmaceuticals (CLVLF) stock?

You can purchase shares of Clinuvel Pharmaceuticals (OTCPK:CLVLF) through any online brokerage.

View our list of the best stock brokerages

Who are Clinuvel Pharmaceuticals (CLVLF) competitors?

There are no as such competitors for Clinuvel Pharmaceuticals.

What is the forecast, or price target, for Clinuvel Pharmaceuticals (CLVLF) stock?

There is no analysis for Clinuvel Pharmaceuticals to provide a consensus price target.

What is the current price for Clinuvel Pharmaceuticals (CLVLF)?

The stock price for Clinuvel Pharmaceuticals (OTCPK: CLVLF) is $8.45 last updated January 27, 2026 at 10:17 AM EST.

Does Clinuvel Pharmaceuticals (CLVLF) pay a dividend?

There are no upcoming dividends for Clinuvel Pharmaceuticals.

When is Clinuvel Pharmaceuticals (OTCPK:CLVLF) reporting earnings?

Clinuvel Pharmaceuticals does not have any upcoming earnings scheduled.

Is Clinuvel Pharmaceuticals (CLVLF) going to split?

There is no upcoming split for Clinuvel Pharmaceuticals.

What sector and industry does Clinuvel Pharmaceuticals (CLVLF) operate in?

Clinuvel Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.